Literature DB >> 14745708

No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.

Assan Jaye1, Ramu Sarge-Njie, Maarten Schim van der Loeff, Jim Todd, Abraham Alabi, Shehu Sabally, Tumani Corrah, Hilton Whittle.   

Abstract

Fewer people infected with human immunodeficiency virus (HIV) type 2 progress to acquired immunodeficiency syndrome, compared with those infected with HIV-1. To understand the immune mechanisms leading to slow progression in HIV-2 infection, cell-mediated immune responses were compared between the 2 infections in asymptomatic subjects with a CD4 cell count > or =20%. Interferon- gamma release from T lymphocytes and the cytotoxicity of CD8+ T lymphocytes were measured by ELISPOT and 51Cr release assays. The level of responses and the proportion of responders were similar in the 2 infections, despite a 20-fold difference in their geometric mean plasma virus loads. The proliferation of CD4+ T helper cells, which was evaluated by thymidine incorporation, was not different between the 2 infections. Contrary to widely held views, our results suggest that nonprogression in HIV-2 infection may not be due to more vigorous immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745708     DOI: 10.1086/381185

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

Authors:  N N Zheng; N B Kiviat; P S Sow; S E Hawes; A Wilson; H Diallo-Agne; C W Critchlow; G S Gottlieb; L Musey; M J McElrath
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.

Authors:  A Eshofonie; M Shim van der Loeff; H Whittle; A Jaye
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

3.  Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Authors:  Wim Jennes; Makhtar Camara; Tandakha Dièye; Souleymane Mboup; Luc Kestens
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Authors:  Sabelle Jallow; Abraham Alabi; Ramu Sarge-Njie; Kevin Peterson; Hilton Whittle; Tumani Corrah; Assan Jaye; Matthew Cotten; Guido Vanham; Samuel J McConkey; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

5.  Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.

Authors:  Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun-Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

6.  Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1.

Authors:  Russell B Foxall; Catarina S Cortesão; Adriana S Albuquerque; Rui S Soares; Rui M M Victorino; Ana E Sousa
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

7.  Novel assays to investigate the mechanisms of latent infection with HIV-2.

Authors:  Michael D Lu; Sushama Telwatte; Nitasha Kumar; Fernanda Ferreira; Holly Anne Martin; Gayatri Nikhila Kadiyala; Adam Wedrychowski; Sara Moron-Lopez; Tsui-Hua Chen; Erin A Goecker; Robert W Coombs; Chuanyi M Lu; Joseph K Wong; Athe Tsibris; Steven A Yukl
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.752

8.  Polyfunctional T cell responses are a hallmark of HIV-2 infection.

Authors:  Melody G Duvall; Melissa L Precopio; David A Ambrozak; Assan Jaye; Andrew J McMichael; Hilton C Whittle; Mario Roederer; Sarah L Rowland-Jones; Richard A Koup
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

9.  Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.

Authors:  Aleksandra Leligdowicz; Louis-Marie Yindom; Clayton Onyango; Ramu Sarge-Njie; Abraham Alabi; Matthew Cotten; Tim Vincent; Carlos da Costa; Peter Aaby; Assan Jaye; Tao Dong; Andrew McMichael; Hilton Whittle; Sarah Rowland-Jones
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.

Authors:  Samuel Victor Nuvor; Marianne van der Sande; Sarah Rowland-Jones; Hilton Whittle; Assan Jaye
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.